Categories

Sign Up to Receive the Latest Trading Tips and News from Prosper



    January 28, 2019

    Trevena Inc. Gives Us An Opportunity To the Upside

    The healthcare and biotech sectors were both bearish today. The overall US equities market declined over 1% during the session, as the markets were unable to find positive news catalysts in the wake of negative earnings results in major names in multiple sectors. This suggests that the markets are beginning to re-evaluate current stock valuations, […]

    Read Article
    January 25, 2019

    Get Behind the Controls With Mike Patton

    Here’s a sneak peek of one of the industry’s most reputable, hands-on trading programs with Mike Patton. Grab a free day pass to one of our live signal trading rooms today>>http://bit.ly/fb-free-pass  

    Read Article
    January 25, 2019

    Concept Therapeutics Caught In the Middle Of A Scandal

    Corcept Therapeutics (CORT) shares were down sharply due to a negative report published by the Southern Investigative Reporting Foundation. In the report, the SIRF laid out an argument essentially accusing the company of colluding with physicians to increase prescriptions of its treatment despite the fact that the treatment was only approved by the FDA for […]

    Read Article
    January 24, 2019

    A Sneaky Trick Utilized By Some Companies Revealed

    Capricor Therapeutics Inc. (CAPR) shares slumped sharply after spiking prior to market open. Shares of the stock were up due to the company highlighting a report detailing significant improvements for muscular dystrophy patients treated with the company’s cell therapy. However, it was noted shortly thereafter by some traders that the report was published back in […]

    Read Article
    January 22, 2019

    Patent News For Altimmune Inc.

    Altimmune Inc. ($ALT) shares traded sharply higher today after patent news. The company’s immunologic-therapeutic was granted a US patent today, potentially setting up the stock for an extended bull run. However, the company has a significant financial strain and no products at phase 3 status, so obtaining additional funding will be an issue. Here’s a […]

    Read Article
    January 22, 2019

    A Peek Behind the Curtains With Mike Patton

    Here’s a sneak peek of one of the industry’s most reputable, hands-on trading programs with Mike Patton. Grab a free day pass to one of our live signal trading rooms today>>http://bit.ly/fb-free-pass  

    Read Article
    January 18, 2019

    Bio-Path Holds Performs A Surprise Reverse Split

    Bio-Path Holdings Inc. (BPTH) was very active in trading today. The company surprised the markets by executing a 1:20 reverse split before today’s open. A reverse split means the company converted every 20 shares into 1 share, adjusting the price of the stock to equal 20X yesterday’s close. This meant the price per share went […]

    Read Article
    January 17, 2019

    A Mixed Bag For Lipocine, Inc.

    Lipocine Inc (LPCN) slumped after opening sharply higher today. The stock rallied in the pre-market due to the company releasing a report detailing apparently positive indications for LPCN for its potential in the treatment of liver fat in hypogonadal males. However, biotech columnist Adam Feuerstein voiced negative comments, stating that he believes the study was […]

    Read Article
    January 15, 2019

    A Cancer Breakthrough?

    Kitov Pharma Ltd (KTOV) was up strongly in trading today due to news regarding one of its products. NT219, which is in a preclinical study, was found to demonstrate a strong anti-cancer effect. The new data revealed that even with a short exposure of cancerous cells to NT219, the drug was sufficient to trigger an […]

    Read Article
    January 14, 2019

    AstraZeneca May Have Gotten Themselves Into Some Hot Water

    AstraZeneca PLC (AZN) was down sharply in trading today on high volume. The apparent reason for the decline is increasing pushes for regulatory action to be taken to address drug prices. Congressional lawmakers introduced a bill to lower drug prices on Friday, and Rep. Cummings opened an investigation into drug prices today. Here’s a recap.

    Read Article